Professor Raymond Reilly, founder of the Centre for Pharmaceutical Oncology, works alongside PhD student Valerie Facca at the Leslie Dan Faculty of Pharmacy.
Imagine a future without cancer. Led by the Union for International Cancer Control (UICC), World Cancer Day aims to save millions of preventable deaths each year by raising awareness and education about cancer, and pressing governments and individuals across the world to take action against the disease.
Stéphane Angers, associate dean of research at the Leslie Dan Faculty of Pharmacy is buoyed by the many recent advances in research. “We understand the biology of cancer in ways we never did before,” says Angers whose research group specializes in using CRISPR-Cas9 technologies to screen cancer stem cells and characterize the genes that are essential for tumor growth. “This has led to genuinely promising new categories of treatment including a new therapeutic antibody for pancreatic cancer that will soon enter human clinical trial.”
"We understand the biology of cancer in ways we never did before"
The Centre for Pharmaceutical Oncology (CPO) at the Leslie Dan Faculty of Pharmacy aims to bridge the gap between research discoveries in cancer biology and the development of new molecular diagnostics and therapeutics for cancer and their advancement to first-in-humans clinical trials.
Raymond Reilly, pharmaceutical oncology scientist and Director of the CPO notes that the Centre has assembled more than 170 scientists and trainees to focus their combined skills and efforts on improving the outcome of cancer patients. Research in the CPO is driven by the need to find better ways to detect cancer, select patients for personalized therapies, and develop new molecularly targeted treatments, especially for the most difficult to treat cancers such as pancreatic cancer, metastatic breast cancer and glioblastoma, a type of brain tumour.
“I envision a future in which almost every cancer will be treatable and curable, since through research we will have discovered the treatments that are needed to achieve this great outcome” said Reilly.
Leslie Dan Faculty of Pharmacy Cancer Research Highlights of 2019
Shining a Spotlight On Cancer Cells
Leslie Dan Faculty of Pharmacy professor Christine Allen designs nanotechnologies to help surgeons identify tumours.
More News
Image
U of T pharmacy students earn national recognition at PDW 2026
Nineteen PharmD pharmacy students participated in Professional Development Week (PDW) 2026 in Québec City, earning national and local awards while contributing to advocacy and professional development initiatives.
Read More
Image
U of T and Moderna partner to advance vaccine science, cancer treatment and AI-driven therapeutics
Supported by Moderna Canada, Rick Lu, a postdoctoral researcher in the Li Lab, is using lipid nanoparticles to deliver precise mRNA instructions, advancing safer and more scalable therapies, including cancer treatments.
Read More
Image
Preparing pharmacy students to lead: Zebrina Kassam named 2026 Leader-in-Residence
New Leader-in-Residence to focus on women in leadership through mentorship and networking opportunities
Read More